BBA reportModulation of HMG-CoA reductase activity by pantetheine/PANTETHINE (cas 138148-35-3)
-
Add time:08/24/2019 Source:sciencedirect.com
The ability of pantetheine/pantethine to modulate the activity of HMG-CoA reductase (EC 1.1.1.34) was determined in vitro with rat liver microsomes. The decay of the activity was obtained with pantethine in the 10 −5-10 −4 M range, whereas stimulation by pantetheine occurred at 10 −3-10 −2 M, as previously reported for GSSG and GSH, respectively. Inhibition of HMG-CoA by pantethine in isolated liver cells was also investigated by measuring the enzyme activity in microsomes isolated from hepatocytes incubated without or with 1 mM pantethine under conditions previously shown by us to induce inhibition of cholesterol synthesis from acetate. The enzyme amount was not modified by pantethine, but in cells treated with the disulphide, the relative amounts of the thiolic active forms of the enzyme, both phosphorylated and dephosphorylated, were decreased to about half compared to controls.
We also recommend Trading Suppliers and Manufacturers of PANTETHINE (cas 138148-35-3). Pls Click Website Link as below: cas 138148-35-3 suppliers
Prev:Research paperEffects of PANTETHINE (cas 138148-35-3) on in-vitro peroxidation of low density lipoproteins☆
Next:PANTETHINE (cas 138148-35-3) stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- PANTETHINE (cas 138148-35-3) stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat08/25/2019
- Research paperEffects of PANTETHINE (cas 138148-35-3) on in-vitro peroxidation of low density lipoproteins☆08/23/2019
- PANTETHINE (cas 138148-35-3), a somatostatin depleting agent, increases food intake in rats☆08/22/2019
- Research paperPANTETHINE (cas 138148-35-3) lipomodulation: evidence for cysteamine mediation in vitro and in vivo08/21/2019
- Reduction of PANTETHINE (cas 138148-35-3) in rabbit ocular lens homogenate08/20/2019
- Review articleTreatment of hyperlipoproteinemia with PANTETHINE (cas 138148-35-3): A review and analysis of efficacy and tolerability08/19/2019
- Original ArticleEfficacy and tolerability of coenzyme A vs PANTETHINE (cas 138148-35-3) for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study08/18/2019
- Original articleComparison of the effects of PANTETHINE (cas 138148-35-3) and fursultiamine on plasma levels of adrenocorticotropic hormone and neuropeptide Y under continual stress exposure08/17/2019


